AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32102910 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low nicotine content (VLNC) cigarettes
Number of subjects: 16
Study 32102910 — intervention group
Group type: COMPARATOR
Intervention: Normal nicotine cigarettes
Number of subjects: 16
Study 36221062 — intervention group
Group type: EXPERIMENTAL
Intervention: EC skin test
Number of subjects: 14579
Study 36221062 — intervention group
Group type: COMPARATOR
Intervention: TST
Number of subjects: 14579
Study 33165125 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine use
Number of subjects: 110
Study 33165125 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher time‐varying sCD14 levels
Number of subjects: 110
Study 33165125 — intervention group
Group type: EXPERIMENTAL
Intervention: Time‐varying detectable viral loads
Number of subjects: 110
Study 33165125 — intervention group
Group type: EXPERIMENTAL
Intervention: Time‐varying reactive urine toxicology results for stimulants
Number of subjects: 110
Study 33165125 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater proviral HIV DNA at baseline
Number of subjects: 110
Study 32844885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 106
Study 32844885 — intervention group
Group type: COMPARATOR
Intervention: Val/Val genotype
Number of subjects: 106
Study 36231316 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week school-based physical activity intervention (24 sessions, 2 sessions/week, 60 min/session)
Number of subjects: 30
Study 36231316 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 33951415 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (150 mg biweekly subcutaneous)
Number of subjects: 300
Study 33951415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 32197105 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-003
Number of subjects: 20099
Study 32197105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20099
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 2μg, n=47
Number of subjects: 245
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 4μg, n=48
Number of subjects: 245
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 6μg, n=46
Number of subjects: 245
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 8μg, n=44
Number of subjects: 245
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 12μg, n=28
Number of subjects: 245
Study 34378087 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n=32
Number of subjects: 245
Study 33187076 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based progressive strength training program (3 days per week for 8 weeks)
Number of subjects: 85
Study 33187076 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 85
Study 33187076 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based progressive strength training program
Number of subjects: 85
Study 35978289 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted exercise intervention (thrice weekly aerobic and progressive resistance training, reducing sedentary time by 30 min)
Number of subjects: 60
Study 35978289 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted exercise intervention
Number of subjects: 60
Study 35978289 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 33935256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (IA)
Number of subjects: 168
Study 33935256 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal anastomosis
Number of subjects: 168
Study 32763640 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU diary intervention with psychoeducation
Number of subjects: 60
Study 32763640 — intervention group
Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 60
Study 35940529 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 160
Study 35940529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 35410769 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 50
Study 35410769 — intervention group
Group type: COMPARATOR
Intervention: No tDCS
Number of subjects: 50
Study 35410769 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 50
Study 33759069 — intervention group
Group type: EXPERIMENTAL
Intervention: PEX glaucoma
Number of subjects: 34
Study 33759069 — intervention group
Group type: EXPERIMENTAL
Intervention: POAG
Number of subjects: 34
Study 33759069 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 33759069 — intervention group
Group type: EXPERIMENTAL
Intervention: POAG and PEX glaucoma
Number of subjects: 34
Study 33759069 — intervention group
Group type: COMPARATOR
Intervention: POAG and Control
Number of subjects: 34
Study 35107399 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates (3 times/week, 60 min session)
Number of subjects: 43
Study 35107399 — intervention group
Group type: COMPARATOR
Intervention: Control group (relaxation activities every two weeks)
Number of subjects: 43
Study 33276816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership’s home visiting program
Number of subjects: 0
Study 34021314 — intervention group
Group type: EXPERIMENTAL
Intervention: EC skin test at 1.0 μg/0.1 mL
Number of subjects: 873
Study 34021314 — intervention group
Group type: EXPERIMENTAL
Intervention: EC skin test at 0.5 μg/0.1 mL
Number of subjects: 873
Study 34021314 — intervention group
Group type: COMPARATOR
Intervention: T-SPOT.TB test
Number of subjects: 873
Study 34021314 — intervention group
Group type: EXPERIMENTAL
Intervention: EC skin test among BCG vaccinated participants
Number of subjects: 873
Study 34021314 — intervention group
Group type: EXPERIMENTAL
Intervention: EC skin test
Number of subjects: 873
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 165
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclothymic disorder
Number of subjects: 165
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (ADHD and cyclothymic disorder)
Number of subjects: 165
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-comorbid cyclothymic patients
Number of subjects: 165
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid patients with both conditions
Number of subjects: 165
Study 34066126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclothymic patients without ADHD
Number of subjects: 165
Study 34066126 — intervention group
Group type: COMPARATOR
Intervention: ADHD patients without cyclothymia
Number of subjects: 165
Study 32572510 — intervention group
Group type: EXPERIMENTAL
Intervention: Periareolar dermis release
Number of subjects: 39
Study 32572510 — intervention group
Group type: COMPARATOR
Intervention: Control (no periareolar dermis release)
Number of subjects: 39
Study 36237122 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg-breakfast
Number of subjects: 30
Study 36237122 — intervention group
Group type: COMPARATOR
Intervention: Cereal-breakfast
Number of subjects: 30
Study 33334939 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose theophylline 100 mg twice daily plus low-dose oral prednisone 5 mg once daily
Number of subjects: 1670
Study 33334939 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose theophylline 100 mg twice daily plus placebo
Number of subjects: 1670
Study 33334939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1670
Study 33334939 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline plus prednisone versus pooled theophylline plus placebo and placebo
Number of subjects: 1670
Study 33334939 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline plus placebo versus placebo
Number of subjects: 1670
Study 33334939 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline plus prednisone versus placebo
Number of subjects: 1670
Study 33584074 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiklean® (32-tablet sodium phosphate)
Number of subjects: 442
Study 33584074 — intervention group
Group type: COMPARATOR
Intervention: Klean‐Prep/Dulcolax® (2-L polyethylene glycol/bisacodyl)
Number of subjects: 442
Study 33584074 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiklean®
Number of subjects: 442
Study 33584074 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiklean® and Klean‐Prep/Dulcolax®
Number of subjects: 442
Study 32250536 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (degludec)
Number of subjects: 0
Study 32250536 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (glargine U100)
Number of subjects: 0
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 5 mg (weeks 1-8)
Number of subjects: 48
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg (2.5 mg weeks 1-2; 5 mg weeks 3-4; 10 mg weeks 5-8)
Number of subjects: 48
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg (5 mg weeks 1-2; 10 mg weeks 3-6; 15 mg weeks 7-8)
Number of subjects: 48
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 5 mg
Number of subjects: 48
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg
Number of subjects: 48
Study 34647404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg
Number of subjects: 48
Study 34647404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33911100 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES with 50 Hz
Number of subjects: 69
Study 33911100 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES with 35 Hz
Number of subjects: 69
Study 33911100 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 36086927 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision plus SVF
Number of subjects: 10
Study 32180266 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping once with pressure ≥50 mmHg
Number of subjects: 50
Study 32180266 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping twice with pressure ≥40 mmHg
Number of subjects: 50
Study 32180266 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping thrice with pressure ≥10 mmHg
Number of subjects: 50
Study 32180266 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping once with pressure ≥5 mmHg
Number of subjects: 50
Study 32180266 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping with at least 10 mmHg or more three times
Number of subjects: 50
Study 34979510 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) surgery
Number of subjects: 38
Study 34979510 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 38
Study 33040678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Imagery (MI) training for 30 min/day for 5 days
Number of subjects: 42
Study 33040678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Imagery (MI) training
Number of subjects: 42
Study 33040678 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 34059080 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of umbilical cord-derived Wharton's jelly (WJ)
Number of subjects: 168
Study 34059080 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 168
Study 34059080 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo control)
Number of subjects: 168
Study 35948970 — intervention group
Group type: EXPERIMENTAL
Intervention: We Can Quit intervention with free nicotine replacement therapy (NRT)
Number of subjects: 21
Study 35948970 — intervention group
Group type: EXPERIMENTAL
Intervention: We Can Quit intervention with group-based support facilitated by trained lay local community facilitators (CFs)
Number of subjects: 21
Study 35948970 — intervention group
Group type: EXPERIMENTAL
Intervention: We Can Quit intervention with free NRT
Number of subjects: 21
Study 35948970 — intervention group
Group type: EXPERIMENTAL
Intervention: Support provided by pharmacists
Number of subjects: 21
Study 35948970 — intervention group
Group type: EXPERIMENTAL
Intervention: Future definitive trial (DT) observational fidelity assessments
Number of subjects: 21
Study 33661694 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention that addressed avoidance and promoted healthy coping strategies
Number of subjects: 235
Study 33661694 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 235
Study 32446306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment group (n = 28)
Number of subjects: 56
Study 32446306 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 28)
Number of subjects: 56
Study 35181523 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental resection
Number of subjects: 55
Study 35181523 — intervention group
Group type: COMPARATOR
Intervention: Nodule excision via shaving or disk excision
Number of subjects: 55
Study 34109778 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 buccal spray (2000 U, n=30) for six weeks
Number of subjects: 90
Study 34109778 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral drops (2000 U, n=30) for six weeks
Number of subjects: 90
Study 34109778 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose (300,000 U, n=30)
Number of subjects: 90
Study 33147541 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg nano-curcumin for two months
Number of subjects: 40
Study 33147541 — intervention group
Group type: COMPARATOR
Intervention: Placebo for two months
Number of subjects: 40
Study 34606932 — intervention group
Group type: EXPERIMENTAL
Intervention: Coverall PPE removal
Number of subjects: 60
Study 34606932 — intervention group
Group type: COMPARATOR
Intervention: Gown PPE removal
Number of subjects: 60
Study 35182352 — intervention group
Group type: EXPERIMENTAL
Intervention: multidomain lifestyle intervention
Number of subjects: 1260
Study 35182352 — intervention group
Group type: COMPARATOR
Intervention: regular health advice
Number of subjects: 1260
Study 33677072 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management (PRISM) intervention
Number of subjects: 0
Study 36174766 — intervention group
Group type: EXPERIMENTAL
Intervention: F2 group (etch-mineralizing solution with 10 mg/ml sodium fluoride)
Number of subjects: 0
Study 36174766 — intervention group
Group type: COMPARATOR
Intervention: Control group (35% phosphoric acid gel treatment)
Number of subjects: 0
Study 36174766 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups (F1, F2, F3)
Number of subjects: 0
Study 36174766 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups
Number of subjects: 0
Study 32524768 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant drugs
Number of subjects: 0
Study 32524768 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization methods
Number of subjects: 0
Study 32101792 — intervention group
Group type: COMPARATOR
Intervention: No fluid (NF)
Number of subjects: 11
Study 32101792 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (WAT)
Number of subjects: 11
Study 32101792 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution (CES)
Number of subjects: 11
Study 35843957 — intervention group
Group type: EXPERIMENTAL
Intervention: CAREDYNE Shield (intervention group)
Number of subjects: 24
Study 35843957 — intervention group
Group type: COMPARATOR
Intervention: Nanoseal (control group)
Number of subjects: 24
Study 32524850 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief multimodal online intervention targeting illness representations about skin cancer
Number of subjects: 509
Study 35500846 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-infusion pump at 2 ml/h without accompanying fluid (Observation group)
Number of subjects: 215
Study 35500846 — intervention group
Group type: COMPARATOR
Intervention: Micro-infusion pump at 2 ml/h with normal saline (Control group)
Number of subjects: 215
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial pain assessment using Visual Analogue Scale (VAS)
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health status measured by DMFT
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health status measured by OHI-S
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological status assessed using Generalized Anxiety Disorder Scale
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological status assessed using Impact of Events Scale
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing frequency and dental visits
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque accumulation measured by OHI-S
Number of subjects: 90
Study 34055118 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status and severity of burn
Number of subjects: 90
Study 32053557 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6.5 ± 1.8 ml/kg predicted body weight)
Number of subjects: 42
Study 32053557 — intervention group
Group type: COMPARATOR
Intervention: Intermediate tidal volume ventilation (9.5 ± 1.6 ml/kg predicted body weight)
Number of subjects: 42
Study 35491787 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM therapy (real light therapy)
Number of subjects: 58
Study 35491787 — intervention group
Group type: COMPARATOR
Intervention: Sham light therapy
Number of subjects: 58
Study 35786297 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy and exercise
Number of subjects: 50
Study 35786297 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care or self-management coping styles
Number of subjects: 50
Study 35786297 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping strategies
Number of subjects: 50
Study 35189818 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate–amodiaquine (AS-AQ)
Number of subjects: 242
Study 35189818 — intervention group
Group type: COMPARATOR
Intervention: Artemether–lumefantrine (AL)
Number of subjects: 242
Study 32036671 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary outpatient palliative care
Number of subjects: 60
Study 32036671 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 36309744 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic pillbox intervention with pre-filled weekly blister pack medication trays, alarms, detection of pill removal, alerts to patients or caregivers, adherence reports, and pharmacist outreach for missed doses.
Number of subjects: 0
Study 33374554 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 24
Study 33374554 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 24
Study 33374554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 24
Study 34474731 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg daily for 3 days)
Number of subjects: 20
Study 34474731 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 33734782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral substance use treatment (standard)
Number of subjects: 70
Study 33734782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral substance use treatment (culturally accommodated)
Number of subjects: 70
Study 32119656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network analysis (BN) with two directional anchors
Number of subjects: 0
Study 32119656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network analysis (BN) with a single directional anchor
Number of subjects: 0
Study 32119656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network analysis (BN) with no directional anchor
Number of subjects: 0
Study 32119656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network analysis (BN)
Number of subjects: 0
Study 32119656 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization (MR)
Number of subjects: 0
Study 32119656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network analysis (BN) incorporating genetic anchors
Number of subjects: 0
Study 34023938 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild blueberry (WBB) drink intervention (766 mg total polyphenols; 253 mg anthocyanins; equivalent to 240 g fresh blueberries per day)
Number of subjects: 15
Study 34023938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 34023938 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild blueberry (WBB) drink intervention
Number of subjects: 15
Study 32739320 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced dose to the posterior prostate and surrounding regions in RADAR and RT01 patients
Number of subjects: 683
Study 32739320 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced dose to the seminal vesicle region in RADAR intermediate-risk patients
Number of subjects: 683
Study 32739320 — intervention group
Group type: COMPARATOR
Intervention: Control group from CHHiP trial
Number of subjects: 683
Study 35470400 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 30
Study 35470400 — intervention group
Group type: COMPARATOR
Intervention: Total sleep deprivation
Number of subjects: 30
Study 35750784 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation experiment teaching platform
Number of subjects: 56
Study 35750784 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 56
Study 36088627 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional vitamin D3
Number of subjects: 100
Study 36088627 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional measles, mumps, and rubella (MMR) vaccine
Number of subjects: 100
Study 34097368 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg on days 1, 15, 168, and 182)
Number of subjects: 135
Study 34097368 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (2 g per day)
Number of subjects: 135